20%-25% drug export rise for Bangladesh
The Bangladesh Association of Pharmaceutical Industries has forecast an increase in the country's drug exports of 20%-25% by the end of 2008, to a range of 30.0 billion-40.0 billion taka ($434.8 million-$579.7 million), according to a report in India's Financial Express newspaper.
The BAPI figures were announced at the end of the association's Asia Pharma Expo - 2007 in Dacca, Bangladesh. At the event, seminars were held on the World Trade Organization's Agreement on Trade-Related Intellectual Property Rights (TRIPS), bio-equivalence and biopharmaceutics classification systems, and the impact of globalization on Bangladesh's drug industry. Organizers added that at least 400 products from 26 countries were exhibited at the exposition.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze